Program Information
· Program

Bio&Medical Technology Development Program

· Directorate

Directorate for National Strategic R&D Programs

· Program objective
-

Secure and support commercialization of core original technology in the fields of bio and state-of-the-art medicine directly related to human life and health such as new drugs and stem cell

· Program details
-

Research areas: 11 areas including development of new drugs and next-generation medical technology

-

Eligibility: Researchers at universities, hospitals, and government-funded and private research institutes

-

Summary: 48 subcategory projects including development of new drug pipelines and next-generation medical equipment platform technology

-

Period: 2~10 years

-

Funding: Annually around KRW 100~10,000 million/project (USD 91~9,091 thousand)

· Contact
-

LIM, Moo Keun, Biotechnology Team2, mklim@nrf.re.kr

· Project process
Announcement
Jan., Mar. and May 2019
Receipt
Feb., Apr. and Jul. 2019
Evaluation
Apr. Jun., and Sep. 2019
Selection
Jun., Aug., and Nov. 2019